Cargando…
Fidaxomicin: Difimicin; Lipiarmycin; OPT 80; OPT-80; PAR 101; PAR-101
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585687/ https://www.ncbi.nlm.nih.gov/pubmed/20509714 http://dx.doi.org/10.2165/11537730-000000000-00000 |
| _version_ | 1782261186159443968 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3585687 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-35856872013-03-04 Fidaxomicin: Difimicin; Lipiarmycin; OPT 80; OPT-80; PAR 101; PAR-101 Drugs R D Adis R&D Profile Springer International Publishing 2012-11-27 2010-05 /pmc/articles/PMC3585687/ /pubmed/20509714 http://dx.doi.org/10.2165/11537730-000000000-00000 Text en © Adis Data Information BV 2010 |
| spellingShingle | Adis R&D Profile Fidaxomicin: Difimicin; Lipiarmycin; OPT 80; OPT-80; PAR 101; PAR-101 |
| title | Fidaxomicin: Difimicin; Lipiarmycin; OPT 80; OPT-80; PAR 101; PAR-101 |
| title_full | Fidaxomicin: Difimicin; Lipiarmycin; OPT 80; OPT-80; PAR 101; PAR-101 |
| title_fullStr | Fidaxomicin: Difimicin; Lipiarmycin; OPT 80; OPT-80; PAR 101; PAR-101 |
| title_full_unstemmed | Fidaxomicin: Difimicin; Lipiarmycin; OPT 80; OPT-80; PAR 101; PAR-101 |
| title_short | Fidaxomicin: Difimicin; Lipiarmycin; OPT 80; OPT-80; PAR 101; PAR-101 |
| title_sort | fidaxomicin: difimicin; lipiarmycin; opt 80; opt-80; par 101; par-101 |
| topic | Adis R&D Profile |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585687/ https://www.ncbi.nlm.nih.gov/pubmed/20509714 http://dx.doi.org/10.2165/11537730-000000000-00000 |